Restoring Balance: Targeting Gut Dysbiosis with Pylopass™ and Immunolin®
Speakers
Sarah Ellis, ND, MS
Holly Lucille, ND, RN
Sign up for Academy to watch
Gain access to evolving research into evidence-based education that supports streamlined whole person care.
About this webinar
Join Dr. Holly Lucille, ND, RN, Medical Advisor at Fullscript, and Dr. Sarah Ellis, ND, MS, Clinical Science Liaison at Microbiome Labs for an insightful discussion on innovative approaches to addressing gut dysbiosis.
This webinar will focus on two cutting-edge technologies. Discover how Pylopass, a patented strain of Lactobacillus reuteri, promotes a balanced gut environment. Additionally, learn about Immunolin, a serum-derived bovine immunoglobulin protein isolate, and its role in supporting immune function and restoring gut integrity.
Our expert speakers will explore the mechanisms of action, clinical evidence, and practical applications of these novel interventions.
Key takeaways
- Gain a comprehensive understanding of gut dysbiosis, its causes, and its implications for overall health.
- Learn how Pylopass, a unique strain of Lactobacillus reuteri, specifically manages Helicobacter pylori, aiding in the restoration of gut balance.
- Discover how Immunolin, a serum-derived bovine immunoglobulin protein isolate, supports immune function and helps to maintain gut integrity.
- Review the latest clinical studies and research findings on the effectiveness of Pylopass and Immunolin in managing gut dysbiosis.
- Explore practical ways to incorporate Pylopass and Immunolin into therapeutic strategies for improving gut health and addressing dysbiosis.
- Discuss emerging trends and future directions in microbiome science, highlighting the potential of innovative technologies to revolutionize gut health management.
